Answers are grounded in this paper and cite their sources.
Longitudinal analysis explores molecular drivers of T cell exhaustion in hepatitis carcinoma, indicating new immunotherapy strategies.
The efficacy of immune checkpoint blockade in hepatocellular carcinoma remains suboptimal, characterized by low objective response rates. Given that the tumor microenvironment plays a pivotal role in determining immune checkpoint blockade effectiveness, a comprehensive understanding of its molecular and cellular dynamics before and after immune checkpoint blockade treatment is crucial. In this study, we conducted single-cell RNA sequencing on fourteen tumor biopsies and eight blood samples obtained from ten hepatocellular carcinoma patients before and after anti-PD-1 therapy, including four paired samples. Our analysis revealed that differential therapeutic responses were associated with distinct T cell states and a progenitor-to-terminal exhaustion trajectory. Developmental trajectory analysis identified key genes implicated in T cell exhaustion and validated the molecular signatures indicative of pro-exhaustion across experimental models. Furthermore, we observed a correlation between T cell exhaustion and malignant epithelial cells. These findings provide important insights into potential strategies for enhancing immunotherapy in advanced hepatocellular carcinoma by targeting T cell exhaustion.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: